Jan 29 (Reuters) - MEVIS MEDICAL SOLUTIONS AG M3VGn.DE :
* FY 2018/2019 SALES INCREASED BY € 0.3 MILLION TO € 18.1
MILLION
* FY 2018/2019 EBIT OF € 8.0 MILLION
* FY 2018/19 EARNINGS AFTER TAXES ROSE BY € 0.5 MILLION TO €
8.1
MILLION
* FOR FY 2019/2020 EXPECTS SIGNIFICANT DECLINE IN SALES TO
BETWEEN
€ 15.5 MILLION AND € 16.0 MILLION
* FOR FY 2019/2020 EXPECTS EBIT TO DECREASE TO € 4.5 MILLION
- €
5.0 MILLION
Source text for Eikon: ID:nEQ6nkSdya
Further company coverage: M3VGn.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))